{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-016039","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2025-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.284967+00:00","generated_at":"2026-05-17T05:23:58.716335+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Akari closes final tranche of August 2025 notes offering for $250K purchase price","bullets":["Aggregate purchase price of $3 million for notes with 20% original issuance discount.","Total principal amount issued approximately $3.8 million across all tranches.","Final tranche: $312,500 principal issued for $250,000 purchase price.","Notes are unsecured promissory notes issued under note purchase agreements dated August 1, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-016039","json":"https://secwatch.observer/filing/0001493152-25-016039.json","markdown":"https://secwatch.observer/filing/0001493152-25-016039.md","text":"https://secwatch.observer/filing/0001493152-25-016039.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/0001493152-25-016039-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:23:58.716335+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}